Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Linden Buys Hycor from Agilent
Feb 2010
CHICAGO & SANTA CLARA, Calif., Feb. 9, 2010 - Linden LLC, a Chicago-based health care private equity firm, has purchased Hycor Biomedical Inc. from Agilent Technologies for an undisclosed amount.

Hycor, located in Garden Grove, Calif., manufactures in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets. Agilent origianlly bought Hycor through its 2007 acquisition of Stratagene.

“We believe Hycor has great opportunities outside of the Agilent portfolio,” said Nick Roelofs, president of Agilent’s Life Sciences Group. “Hycor is an innovative, profitable and growing business, but it does not fit the core focus of our life science business. Agilent is pleased that Linden is the buyer because of its strong health care and diagnostics expertise coupled with its track record of investing in and growing businesses.”

Richard Novak, a Linden operating partner and former chief operating officer of Laboratory Corporation of America, will serve as Hycor's chairman.

For more information, visit:

Agilent TechnologiesallergyautoimmunityBiophotonicsBusinessCaliforniadiagnosticsEmploymentGarden GroveHycor BiomedicalIllinoisin vitroLaboratory Corporation of AmericaLindenNick RoelofsRichard NovakStratageneurinalysis

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.